UPDATE - UBS initiates coverage on Auxilium Pharmaceuticals (NASDAQ: AUXL) with a Buy. PT $30.

UBS analyst says, "We expect ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE